The Oncotype DX® 21-gene recurrence score and clinical outcomes in hormone receptor-positive, HER2-negative male breast cancer: a scoping review.
Saved in:
| Title: | The Oncotype DX® 21-gene recurrence score and clinical outcomes in hormone receptor-positive, HER2-negative male breast cancer: a scoping review. |
|---|---|
| Authors: | Mezi S; Department of Radiological, Oncological and Pathological Sciences, Sapienza University of Rome, Rome, Italy., Pomati G; Clinical Oncology Unit, Istituto Neurotraumatologico Italiano (I.N.I), Grottaferrata, Italy., Chiavassa A; Department of Radiological, Oncological and Pathological Sciences, Sapienza University of Rome, Rome, Italy., Silvestri V; Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy., Ottini L; Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy. laura.ottini@uniroma1.it. |
| Source: | Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico [Clin Transl Oncol] 2026 May; Vol. 28 (5), pp. 1652-1661. Date of Electronic Publication: 2025 Nov 23. |
| Publication Type: | Journal Article; Scoping Review; Review |
| Journal Info: | Publisher: Springer Italia Country of Publication: Italy NLM ID: 101247119 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1699-3055 (Electronic) Linking ISSN: 1699048X NLM ISO Abbreviation: Clin Transl Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1699-3055 |
|---|---|
| DOI: | 10.1007/s12094-025-04110-w |
